Scholar Rock Holding Corporation's Stock Performance and Analyst Ratings
Michael Yee from UBS set a price target of $60 for NASDAQ:SRRK, indicating a potential increase of approximately 45.24%.The average 12-month price target among analysts is $48.9, with Barclays raising its target to $52.Despite a recent 3.39% decrease, analyst ratings such as "overweight" from Cantor Fitzgerald and "outperform" from Wolfe Research show strong confidence in the stock's future performance.Scholar Rock Holding Corporation, trading on NASDAQ under the symbol SRRK, is a biopharmaceutical company ...